Intezyne Technologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.intezyne.com
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Phase 1
Terminated
- Conditions
- CancerNeoplasmsTumorsRefractory Solid TumorsRecurrent Solid Tumors
- Interventions
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Intezyne Technologies, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03096340
- Locations
- 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸Mary Crowley Cancer Research Centers - Medical City, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath